Company Overview
Snapshot
Founded in March 2019 by Andrea Heimann, PeptiCanna operated with 1–10 employees. The company holds a patent for its core technology.
Business overview
PeptiCanna is a Health Tech & Life Sciences company focused on drug discovery and development within the pharmaceutical sector. The company has developed a novel, patent-granted peptide designed to improve metabolic parameters for treating obesity and type 2 diabetes, specifically engineered to avoid adverse central nervous system effects. PeptiCanna's technology targets the pharmaceutical market, operating within the Drugs Discovery & Development and Pharma & Medical Biotechnology sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is PeptiCanna's primary focus?
- PeptiCanna focuses on developing a novel patent-granted peptide to improve metabolic parameters for treating obesity and type 2 diabetes without adverse central nervous system effects.
- When was PeptiCanna founded?
- PeptiCanna was founded in March 2019.
- Who founded PeptiCanna?
- PeptiCanna was founded by Andrea Heimann.
- What is the status of PeptiCanna's operations?
- PeptiCanna is currently non-active, having ceased operations in December 2019.
- Does PeptiCanna hold any patents?
- Yes, PeptiCanna holds a patent for its developed peptide technology.